ECM
RMD icon

ETrade Capital Management’s ResMed RMD Stock Holding History

ETrade Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-9,027
Closed -$935K – 840
2018
Q2 		$935K Buy
9,027
+561
+7% +$56.8K 0.03% 379
2018
Q1 		$834K Buy
8,466
+869
+11% +$82.1K 0.03% 394
2017
Q4 		$643K Buy
7,597
+230
+3% +$19K 0.02% 443
2017
Q3 		$567K Buy
+7,367
New +$564K 0.02% 437

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ETrade Capital Management's RMD Position: Q3 2018 in Review

ETrade Capital Management sold out of ResMed (RMD) in Q3 2018, closing a stake of 9,027 shares — an estimated $935K sold.

ETrade Capital Management first reported a position in RMD in Q3 2017 and held it in 4 quarters. The position peaked at $935K in Q2 2018. 497 funds tracked by Wall St. Rank hold RMD as of Q3 2018.

  • ETrade Capital Management reported no remaining ResMed position as of Q3 2018 after selling out during the quarter.
  • ETrade Capital Management sold 9,027 ResMed shares in Q3 2018, an estimated $935K.
  • ETrade Capital Management first reported a position in ResMed in Q3 2017 and held it in 4 quarters.
  • ETrade Capital Management's ResMed position peaked at $935K in Q2 2018.
  • 497 funds tracked by Wall St. Rank held ResMed as of Q3 2018.

Based on ETrade Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.